NASDAQ:PCVX
Vaxcyte, Inc. Stock News
$74.57
-0.88 (-1.17%)
At Close: May 17, 2024
VAX-24 is a 24-Valent Broad-Spectrum Pneumococcal Conjugate Vaccine Leveraging Vaxcyte's Technology Platform VAX-24 is a 24-Valent Broad-Spectrum Pneumococcal Conjugate Vaccine Leveraging Vaxcyte's Te
Vaxcyte to Present at 20th Annual Needham Virtual Healthcare Conference
04:30pm, Monday, 05'th Apr 2021
FOSTER CITY, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines desig
Vaxcyte, Inc. (PCVX) CEO Grant Pickering on Q4 2020 Results - Earnings Call Transcript
08:22pm, Monday, 29'th Mar 2021
Vaxcyte, Inc. (PCVX) CEO Grant Pickering on Q4 2020 Results - Earnings Call Transcript
Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
04:10pm, Monday, 29'th Mar 2021
FOSTER CITY, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines desig
Vaxcyte asks chairman Slaoui to resign after GSK harassment allegation
06:48am, Thursday, 25'th Mar 2021
U.S. vaccine developer Vaxcyte Inc on Thursday asked board chairman Moncef Slaoui to step down, a day after GlaxoSmithKline dismissed him as an independent probe found he had sexually harassed a GSK e
TPG Group Holdings (SBS) Advisors, Inc. Buys C3..
07:38pm, Wednesday, 24'th Mar 2021
Fort Worth, TX, based Investment company TPG Group Holdings (SBS) Advisors, Inc. (Current Portfolio) buys C3.ai Inc, McAfee Corp, Vaxcyte Inc, Eros STX Global Corp, Thomson Reuters Corp, sells Uber Te
Vaxcyte to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021
04:05pm, Monday, 22'nd Mar 2021
FOSTER CITY, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines desig
FOSTER CITY, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent o
U.S. IPO Week Ahead: DoorDash And Airbnb Kick Off The Unicorn Parade In A 6 IPO Week
02:26pm, Sunday, 06'th Dec 2020
The unicorn IPO parade is set to begin in the week ahead, with DoorDash and Airbnb leading the way. A total of six IPOs and two SPACs are scheduled to raise $7.2 billion.
Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update
04:15pm, Thursday, 12'th Nov 2020
FOSTER CITY, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel va
Vaxcyte to Present at Jefferies Virtual London Healthcare Conference
04:41pm, Tuesday, 10'th Nov 2020
FOSTER CITY, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel va
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 17)
Catalent Inc (NYSE: CTLT)
CureVac N.V. (NASDAQ: CVAC) (follow-on buying after a 250% advance on its debut Friday...
Dow Jones Edges Higher In New Bid For 28,000; Tesla, AMAT Stock Lead Nasdaq
07:01pm, Friday, 14'th Aug 2020
The Dow Jones held a modest gain late Friday, buoyed by a 2% gain for Boeing stock. A strong earnings report lifted AMAT stock in the Nasdaq 100.
CORRECTION – Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
08:59pm, Wednesday, 12'th Aug 2020
FOSTER CITY, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by Vaxcyte, Inc. (Nasdaq: PCVX), please note that in the first bullet under “Recent
Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
08:10pm, Wednesday, 12'th Aug 2020
FOSTER CITY, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel va
